Medicija has acquired Saulės Šeimos Medicinos Centras
May 2026 — Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Medicija is a leading fertility services provider in Lithuania with a growing offering across multiple specialist consultation areas. It operates three modern clinics in Vilnius, Kaunas and Klaipėda.
Founded 25 years ago by five family doctors, Saulės Šeimos Medicinos Centras is the largest primary healthcare provider in the Kaunas region, operating four state-of-the-art clinics in the city. The company serves approximately 28,000 registered patients and employs 170 people.
Our role in the transaction
Oaklins’ team in Lithuania acted as the financial advisor to Medicija in the acquisition. This transaction marks the team’s third engagement with Medicija, strengthening the company’s position in the Lithuanian healthcare services market and laying a solid foundation for future growth.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more